Small Cell Lung Cancer (SCLC)

Latest News

Olvi-Vec Exhibits Preliminary Efficacy in Advanced Small Cell Lung Cancer

March 27th 2025

Intravenous olvi-vec demonstrated a manageable safety and tolerability profile consistent with previous trials evaluating the investigational agent.

Atezolizumab Combo Real-World Data Match Clinical Trial Efficacy in SCLC

By Tim Cortese

March 20th 2025

3 Things You Should Know About Recognizing LEMS in Patients With SCLC

By ONCOLOGY Staff

March 12th 2025

Pooled analysis data support atezolizumab continuation as a viable second-line therapy option in extensive-stage small cell lung cancer.

Continued Atezolizumab Shows Durable Benefit in Pretreated ES-SCLC

By Russ Conroy

March 9th 2025

Orphan Drug Designation Granted to 225Ac-SSO110 for SCLC

By Tim Cortese

February 8th 2025

Latest CME Events & Activities

Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care

26th Annual International Lung Cancer Congress®

July 25-26, 2025

20th Annual New York Lung Cancers Symposium®

November 15, 2025

Cases & Conversations™: Integrating Novel Approaches to Treatment in First-line ALK+ mNSCLC – Enhancing Patient Outcomes with Real World Multidisciplinary Strategies

Annual Hawaii Cancer Conference

January 24-25, 2026

A Breath of Strength: Managing Cancer Associated LEMS and Lung Cancer as One

Striking the Right Nerve: Managing Cancer Associated LEMS in Lung Cancer Patients

Virtual Testing Board: Digging Deeper on Your Testing Reports to Elevate Patient Outcomes in Advanced Non–Small Cell Lung Cancer

More News

Findings Show Resistance Mechanisms in Small Cell Lung Cancer

Kristie L. Kahl

March 3rd 2020

A study, published in Nature Cancer, demonstrates the quick and evolving revolutions of resistance mechanisms in small cell lung cancer.

<1 2 3 4

Do Not Sell My Personal Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777